Misuse Of Drugs – Page 4

Misuse Of Drugs – Page 4

Page 1 | Page 2 | Page 3 | Page 4 | Page 5

Misuse of Drugs, Offences, Confiscation and Money Laundering

Page 4 – Class C Drugs (continued)




Fencamfamin {53}
Fenethylline {54}
Fenproporex {55}
Fludiazepam {56}
Flunitrazepam {57}
Flurazepam
Gamma–butyrolactone {117}
Halazepam {58}
Haloxazolam {59}
4-Hydroxy-n-butyric acid {98}
Ketamine {107a}
Ketazolam {60}
Loprazolam {61}
Lorazepam {62}
Lormetazepam {63}
Mazindol {64}
Medazepam {65}
Mefenorex {66}
Mephentermine
Meprobamate {67}
Mesocarb {93}
[Methaqualone] {68}
Methyprylone {69}
Midazolam {70}
Nimetazepam {71}
Nitrazepam {72}
Nordazepam {72}
Oxazepam {73}
Oxazolam {74}
Pemoline {75}
Phendimetrazine
Phentermine {76}
Pinazepam {77}
[Pipradol] {121}
Prazepam {78}
[Prolintane] {79}
[Propylhexedrine] {80}
Pyrovalerone {81}
Temazepam {82}
Tetrazepam {83}
Triazolam {84}
N-Ethylamphetamine {85}
Zolpidem {99}

(b)
5a–Androstane–3,17–diol.{117}

Androst-4-ene-3,17-diol. {117}
1–Androstenediol {117}
1–Androstenedione]{117}
4-Androstene-3, 17-dione.{117}
[5–Androstenedione{117}
5-Androstene-3, 17-diol
Atamestane.
Bolandiol.
Bolasterone.
Bolazine.
Boldenone.
Boldione {117}
Bolenol.
Bolmantalate.
1,4–Butanediol {117}
Calusterone.
4-Chloromethandienone.
Clostebol.
Danazol {117}
Desoxymethyltestosterone {117}
Drostanolone.
Enestebol.
Epitiostanol.
Ethyloestrenol.
Fluoxymesterone.
Formebolone.
Furazabol.
Gestrinone {117}
3–Hydroxy–5–androstan–17–one {117}
Mebolazine.
Mepitiostane.
Mesabolone.
Mestanolone.
Mesterolone.
Methandienone.
Methandriol.
Methenolone.
Methyltestosterone.
Metribolone.
Mibolerone.
Nandrolone.
19–Norandrostenedione {117}
19-Nor-4-Androstene-3, 17-dione
19-Nor-5-Androstene-3, 17-diol
19–Norandrosterone {117}
Norboletone.
Norclostebol.
Norethandrolone.
19–Noretiocholanolone {117}

Oripavine {117}
Ovandrotone.
Oxabolone.
Oxandrolone.
Oxymesterone.
Oxymetholone.
Pipradrol {123}
Prasterone.
Propetandrol.
Prostanozol {117}
Quinbolone.
Roxibolone.
Silandrone.
Stanolone.
Stanozolol.
Stenbolone.
Testosterone.
Tetrahydrogestrinone {117}
Thiomesterone.
Trenbolone.

(c ) any compound (not being Trilostane or a compound for the time being specified in sub-paragraph (b) above) structurally derived from 17-hydroxyandrostan-3-one or from 17-hydroxyestran-3-one by modification in any of the following ways, that is to say,
(i) by further substitution at position 17 by a methyl or ethyl group;
(ii) by substitution to any extent at one or more of positions 1, 2, 4, 6, 7, 9, 11 or 16, but at no other position;
(iii) by unsaturation in the carbocylic ring system to any extent, provided that there are no more than two ethylenic bonds in any one carbocyclic ring;
(iv) by fusion of ring A with a heterocyclic system;

(ca) 1–benzylpiperazine or any compound structurally derived from 1–benzylpiperazine or 1–phenylpiperazine by modification in any of the following ways—
(i) by substitution at the second nitrogen atom of the piperazine ring with alkyl, benzyl, haloalkyl or phenyl groups;
(ii) by substitution in the aromatic ring to any extent with alkyl, alkoxy, alkylenedioxy, halide or haloalkyl groups. {117}

(d) any substance which is an ester or ether (or, where more than one hydroxyl function is available, both an ester and an ether) of a substance specified in sub-paragraph (b) or described in sub-paragraph (c) above [or of cannabinol or a cannabinol derivative] {104}{112};

(e) Chorionic Gonadotrophin (HCG)
Clenbuterol
Non-human chorionic gonadotrophin
Somatotropin
Somatrem
Somatopin
Zeranol {117}

Zilpaterol {117}

2. Any stereoisometric form of a substance for the time being specified in paragraph 1 of this part of this Schedule not being phenylpropanolamine.86

3. Any salt of a substance for the time being specified in any of paragraph 1 or 2 of this Part of this Schedule.

4. Any preparation or other product containing a substance for the time being specified in any of paragraphs 1 to 3 of this Part of this Schedule”.


1 The letter “(a)” was added by S.I. 1977 No. 1243, art. 3(a).
2 Inserted by S.I. 1984 No. 859, art 2(2)(a).
2A Reclassified and moved to Class C, 29th January 2004: SI 2003 No. 3201.
3 Inserted by S.I. 1986 No. 2230, art 2(2)(a).
3A Inserted by S.I. 2003 No. 1243
4 Inserted by S.I. 1975 No. 421, art 3(a).
5 Inserted by S.I. 1973 No. 771, art 2(a).
6 Inserted by S.I. 1984 No. 859, art 2(2)(b).
7 Inserted by S.I. 1986 No. 2230, art 2(2)(a).
8 Omitted by S.I. 1973 No. 771, art 2(a).
9 Inserted by S.I. 1979 No. 299, art 2.
10 Inserted by S.I. 1984 No. 859, art 2(2)(c).
11 Inserted by S.I. 1983 No. 765, art 2(a).
12 Inserted by S.I. 1984 No. 859, art 2(2)(d).
13 Inserted by S.I. 1975 No. 765, art 2(a).
14 Inserted by S.I. 1975 No. 421, art 3(b).
15 Inserted by S.I. 1990 No. 2589.
16 Inserted by S.I. 1990 No. 2589.
17 Subparagraph (b) was inserted by S.I. 1977 No. 1243, art 3(b).
18 Paragraph (c) was added by S.I. 1977 No. 1243, art. 3(c).
19 The entire paragraph was inserted by S.I. 1986 No. 2230, art 2(2)(b).
20 The entire paragraph was inserted by S.I. 1986 No. 2230, art 2(2)(b).
21 The words “not being a substance for the time being specified in Part II of this Schedule” were added by S.I. 1973 No. 771, art.2(b).
22 The letter “(a)” was inserted by S.I. 1984 No. 859, art. 2(3)(a).
23 Omitted by S.I. 1985 No. 1995, art. 2(2)(a). The drug is a stereisomeric form of amphetamine and is included in Part II by way of paragraph 2.
24 Inserted by S.I. 1985 No. 1995, art 2(2)(b).
25 Inserted by S.I. 1985 No. 1995, art 2(2)(b).
26 Inserted by S.I. 1984 No. 859, art 2(3)(b).
27 Moved from Class C to Class B by S.I. 1984 No. 859, paras. 2(3)(b), 2(4)(b).
28 Inserted by S.I. 1984 No. 859, art. 2(3)(c) following concern regarding barbiturate abuse.
29 Inserted by S.I. 1973 No. 771, art 2(c).
30 Inserted by S.I. 1985 No. 1995, art 2(2)(c).
31 Inserted by S.I. 1973 No. 771, art 2(c).
32 Inserted by S.I. 1984 No. 859, art 2(3)(d) following concern regarding the misuse of barbiturates (whether intentionally abused or not).
33 Inserted by S.I. 1985 No. 1995, art 2(3).
34 Inserted by S.I. 1985 No. 1995, art 2(3).
35 Inserted by S.I. 1989 No. 1340, art 2(a).
36 Inserted by S.I. 1985 No. 1995, art 2(3).
37 Inserted by S.I. 1986 No. 2230, art 2(3)(a).
38 Inserted by S.I. 1986 No. 2330, art 2(3)(a).
39 Inserted by S.I. 1985 No. 1995, art 2(3).
40 Inserted by S.I. 1985 No. 1995, art 2(3)(c).
41 Inserted by S.I. 1985 No. 1995, art 2(3)(c).
42 Inserted by S.I. 1985 No. 1995, art 2(3)(c).
43 Inserted by S.I. 1985 No. 1995, art 2(3)(c).
44 Inserted by S.I. 1985 No. 1995, art 2(3)(c).
45 Inserted by S.I. 1985 No. 1995, art 2(3)(c).
46 Inserted by S.I. 1983 No. 765, art 2(b).
47 Inserted by S.I. 1985 No. 1995, art 2(3)(d).
48 Inserted by S.I. 1984 No. 859, art 2(4).
49 Inserted by S.I. 1985 No. 1995, art 2(3)(e).
50 Inserted by S.I. 1985 No. 1995, art 2(3)(e).
51 Inserted by S.I. 1985 No. 1995, art 2(3)(e).
52 Inserted by S.I. 1985 No. 1995, art 2(3)(e).
53 This drug was originally included in Part III but subsequently omitted by S.I. 1973 No. 771, art. 2(d) and re-inserted by S.I. 1986, No. 2230, art. 2(3)(b).
54 Inserted by S.I. 1986 No. 2230, art 2(3)(b).
55 Inserted by S.I. 1986 No. 2230, art 2(3)(b).
56 Inserted by S.I. 1985 No. 1995, art 2(3)(e).
57 Inserted by S.I. 1985 No. 1995, art 2(3)(e).
58 Inserted by S.I. 1985 No. 1995, art 2(3)(e).
59 Inserted by S.I. 1985 No. 1995, art 2(3)(e).
60 Inserted by S.I. 1985 No. 1995, art 2(3)(e).

Page 1 | Page 2 | Page 3 | Page 4 | Page 5